Negotiated or bid drugs added to national reimbursement drug list (annual)
Number of drugs admitted to a national reimbursement drug list through price negotiations or competitive bidding.
Unit Count Industry Pharmaceuticals
The chart
The figure
One published observation so far. A chart follows as soon as a second period is published.
Negotiated or bid drugs added to national reimbursement drug list (annual)
China, 2024
Every record
All records
1 record · 1 region · 2024
| Period | Value | Source | Type |
|---|---|---|---|
| China 1 record | |||
| 2024 | 89 | State Council · 31 Dec 2024 | actual |
Primary documents
Sources
1 document. Each links to the publisher's own copy.
| Document | Publisher | Published | Data points |
|---|---|---|---|
| 2024年版国家医保药品目录出炉，新增91种药品——让参保人用上更多新药好药_政策解读_中国政府网 | State Council | — | 1 |
Cite & reuse
Cite this page
Data on this page is published under CC BY 4.0. You may reuse it, including commercially, provided you attribute it. To cite one figure, open its record: each carries APA, MLA, Chicago and BibTeX forms that credit the original publisher.
StatOrigin. (2026). Negotiated or bid drugs added to national reimbursement drug list (annual). Retrieved from https://statorigin.org/indicators/negotiated-or-bid-drugs-added-to-national-reimbursement-drug-list-annual